Presentation JIM 2020

Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option

Presenter: Marco Ferlini

February 13, 2020

REGISTER for free or LOG IN to view this content

Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option

Coronary

ACS/AMI

Presentation

JIM 2020

Antiplatelet Therapy

STEMI

NSTEMI

Up Next

Presentation JIM 2020

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Presenter: Dominick Angiolillo

February 13, 2020

More slides +

Presentation JIM 2020

Antegrade Tips & Tricks

Presenter: Jacopo Oreglia

February 13, 2020

Presentation JIM 2020

Tips And Tricks In Retrograde CTO PCI

Presenter: Roberto Garbo

February 13, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.